In patients with long-standing T2D, Alexandraki et al. [31] observed an upregulation of pro-inflammatory molecules, including IL-6, IL-1β, high-sensitivity CRP, and TNF-a, as well as a higher number of cytokine-secreting cells compared to normoglycemic controls. The gene discussed is CRP; the disease is type 2 diabetes mellitus.